Intelligent Investor

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $4.160 0.14 (3.48%)

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1,252 Regis Healthcare Investor Presentation 1H FY22 Results 23 Feb 2022 8:25AM $1.930 $4.160 $3.900 risen by 115.54%
$1,252 Regis Healthcare 4D And Financial Report 1H FY22 23 Feb 2022 8:23AM $1.930 $4.160 $3.900 risen by 115.54%
$1,252 Initial Director's Interest Notice 19 Jan 2022 8:46AM $1.820 $4.160 $3.900 risen by 128.57%
$1,252 Appointment of Non-executive Director and Operations Update 17 Jan 2022 9:49AM $1.820 $4.160 $3.900 risen by 128.57%
$1,252 Non-Cash Impact of Removal of Aged Care Approval Rounds 13 Dec 2021 9:47AM $1.720 $4.160 $3.900 risen by 141.86%
$1,252 Notification regarding unquoted securities - REG 29 Nov 2021 9:04AM $1.790 $4.160 $3.900 risen by 132.40%
$1,252 Notification regarding unquoted securities - REG 24 Nov 2021 3:33PM $1.860 $4.160 $3.900 risen by 123.66%
$1,252 Change Of Director's Interest Notice 24 Nov 2021 3:27PM $1.865 $4.160 $3.900 risen by 123.06%
$1,252 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $4.160 $3.900 risen by 112.24%
$1,252 Final Director's Interest Notice 28 Oct 2021 9:44AM $1.960 $4.160 $3.900 risen by 112.24%
$1,252 Appointment of Company Secretary 27 Oct 2021 10:07AM $2.000 $4.160 $3.900 risen by 108%
$1,252 Regis Healthcare - Results Of Annual General Meeting 26 Oct 2021 1:19PM $2.015 $4.160 $3.900 risen by 106.45%
$1,252 Regis Healthcare - Chairman And MD Addresses To AGM 26 Oct 2021 9:41AM $2.020 $4.160 $3.900 risen by 105.94%
$1,252 Application for quotation of securities - REG 28 Sep 2021 11:14AM $2.070 $4.160 $3.900 risen by 100.97%
$1,252 Annual Report To Shareholders 23 Sep 2021 12:23PM $2.120 $4.160 $3.900 risen by 96.23%
$1,252 Notice of Annual General Meeting/Proxy Form 23 Sep 2021 12:14PM $2.120 $4.160 $3.900 risen by 96.23%
$1,252 Appendix 4G And Corporate Governance Statement 23 Sep 2021 12:12PM $2.120 $4.160 $3.900 risen by 96.23%
$1,252 Regis Healthcare Investor Presentation FY2021 Results 31 Aug 2021 8:14AM $1.970 $4.160 $3.900 risen by 111.17%
$1,252 Regis Healthcare Results Announcement FY2021 31 Aug 2021 8:13AM $1.970 $4.160 $3.900 risen by 111.17%
$1,252 Dividend/Distribution - REG 31 Aug 2021 8:12AM $1.970 $4.160 $3.900 risen by 111.17%
$1,252 Regis Healthcare Appendix 4E and Financial Report FY2021 31 Aug 2021 8:12AM $1.970 $4.160 $3.900 risen by 111.17%
$1,252 AGM Date 16 Aug 2021 9:07AM $1.960 $4.160 $3.900 risen by 112.24%
$1,252 Statement regarding Employee Underpayments 9 Aug 2021 8:14AM $2.100 $4.160 $3.900 risen by 98.10%
$1,252 Notification of FY21 Full Year Results Date 26 Jul 2021 12:00PM $1.930 $4.160 $3.900 risen by 115.54%
$1,252 Change of Company Secretary 15 Jul 2021 12:59PM $1.978 $4.160 $3.900 risen by 110.37%

76 - 100 of 285 results

Page 4 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.